Methylene Blue IV Dosing in Refractory Shock

Initial Bolus Dosing

The American Journal of Hematology recommends an initial dose of 1-2 mg/kg (0.2 mL/kg of a 1% solution) administered intravenously over 3-5 minutes 1, 2, 3
If no significant improvement in hemodynamics occurs within 30-60 minutes, a repeat dose of 1 mg/kg may be administered, as suggested by the American Journal of Hematology 1, 3
Methylene blue should reduce methemoglobin levels significantly within one hour of administration, according to the American Journal of Hematology 3
Total cumulative dosing should not exceed 7 mg/kg due to risk of worsening methemoglobinemia at higher doses, as recommended by the American Journal of Hematology 1, 4

For prolonged refractory shock or continued methemoglobin production, a continuous IV infusion of 0.10-0.25 mg/kg/hour may be used, as suggested by the American Journal of Hematology 1, 3

Methylene blue is contraindicated in patients with G6PD deficiency as it can cause hemolytic anemia and paradoxically worsen methemoglobinemia, according to the American Journal of Hematology and Praxis Medical Insights 1, 5
Ideally, all patients should be tested for G6PD deficiency before administration, or at minimum, a family history should be obtained, as recommended by the American Journal of Hematology 3, 4
Use with caution in patients taking selective serotonin reuptake inhibitors or other serotonergic medications due to risk of serotonin syndrome, as cautioned by the American Journal of Hematology and Praxis Medical Insights 3, 5
Methylene blue should be used cautiously in pregnant women due to potential teratogenicity, as warned by the American Journal of Hematology and Praxis Medical Insights 3, 5
Caution is warranted in patients with renal failure, according to Praxis Medical Insights 5

This mechanism differs from its action in methemoglobinemia, where it acts as a cofactor to reduce methemoglobin to hemoglobin in erythrocytes, as described by Praxis Medical Insights 5